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Abstract
Objective. To establish an open framework for developing plan optimization models for knowledgebased planning (KBP). Approach. Our framework includes radiotherapy treatment data (i.e. reference
plans) for 100 patients with head-and-neck cancer who were treated with intensity-modulated
radiotherapy. That data also includes high-quality dose predictions from 19 KBP models that were
developed by different research groups using out-of-sample data during the OpenKBP Grand
Challenge. The dose predictions were input to four ﬂuence-based dose mimicking models to form 76
unique KBP pipelines that generated 7600 plans (76 pipelines × 100 patients). The predictions and
KBP-generated plans were compared to the reference plans via: the dose score, which is the average
mean absolute voxel-by-voxel difference in dose; the deviation in dose-volume histogram (DVH)
points; and the frequency of clinical planning criteria satisfaction. We also performed a theoretical
investigation to justify our dose mimicking models. Main results. The range in rank order correlation
of the dose score between predictions and their KBP pipelines was 0.50–0.62, which indicates that the
quality of the predictions was generally positively correlated with the quality of the plans. Additionally,
compared to the input predictions, the KBP-generated plans performed signiﬁcantly better
(P < 0.05; one-sided Wilcoxon test) on 18 of 23 DVH points. Similarly, each optimization model
generated plans that satisﬁed a higher percentage of criteria than the reference plans, which satisﬁed
3.5% more criteria than the set of all dose predictions. Lastly, our theoretical investigation
demonstrated that the dose mimicking models generated plans that are also optimal for an inverse
planning model. Signiﬁcance. This was the largest international effort to date for evaluating the
combination of KBP prediction and optimization models. We found that the best performing models
signiﬁcantly outperformed the reference dose and dose predictions. In the interest of reproducibility,
our data and code is freely available.

1. Introduction
Automated radiotherapy planning is transforming clinical practice and personalized cancer treatment
(Moore 2019). The most common type of automated planning is knowledge-based planning (KBP), which
leverages knowledge derived from historical clinical treatment plans to generate new treatment plans without
human intervention (Cornell et al 2020, Kaderka et al 2021, McIntosh et al 2021). Most common KBP methods
are formulated as a two-stage pipeline (see ﬁgure 1) that ﬁrst predicts the dose that should be delivered to a
patient (Kearney et al 2018, Nguyen et al 2019) and then converts that prediction into a treatment plan via
optimization (Babier et al 2021a, Eriksson and Zhang 2022). Both stages of this pipeline, which are active areas of
research, can signiﬁcantly affect the quality of generated treatment plans (Babier et al 2020). The contributions of
this paper are twofold: (1) to provide data that supports KBP optimization research at scale and (2) to establish a
connection between dose mimicking (a type of KBP optimization) and conventional planning methods. We
expand on the impact of these contributions throughout this paper.
Comparing the quality of competing KBP models from the research community is difﬁcult because the vast
majority of research is conducted with large private datasets, as noted in several reviews (Hussein et al 2018, Ge
and Wu 2019, Wang et al 2020, Momin et al 2021). To help address this issue, the Open Knowledge-Based
Planning (OpenKBP) Grand Challenge was organized to facilitate the largest international effort to date for
developing and comparing dose prediction models on a single open dataset (Babier et al 2021b). The OpenKBP
dataset, which includes data for 340 patients with head-and-neck cancer who were treated with intensity
modulated radiotherapy (IMRT), is limited to dose prediction research (i.e. it is incompatible with KBP
optimization research). Although there are still no open datasets for KBP optimization research, there are two
open datasets that support research in other areas of plan optimization (Craft et al 2014, Breedveld and
Heijmen 2017). However, it is challenging to use these datasets in KBP plan optimization research for two
reasons. First, neither dataset includes dose predictions, which are the input to KBP plan optimization models.
Second, they are small datasets (123 patients total) that span multiple sites (prostate, liver, and head-and-neck)
and multiple modalities (CyberKnife, volumetric modulated arc therapy, proton therapy, and IMRT). While
such a diversity in cases is important to demonstrate the robustness and generalizability of optimization
algorithms across sites and modalities, this same diversity is a disadvantage when it comes to training dose
prediction models, since there is insufﬁcient data for any one site-modality pair (Boutilier et al 2016).
2
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Figure 1. An overview of a complete knowledge-based planning pipeline.

Figure 2. An overview of our methods. A full description of each component is provided in its corresponding subsection.

There are several types of KBP optimization models that translate dose predictions into treatment plans. One
major type of KBP optimization model is dose mimicking, which generally generates a plan that is similar to an
input prediction based on linear (Kierkels et al 2019) or quadratic (McIntosh et al 2017) differences. Another
type of KBP optimization model is inverse planning weight estimation, which optimizes patient-speciﬁc
parameters that make an input dose prediction optimal in a conventional planning model (Chan et al 2014).
However, both types of models can also use information beyond a single dose prediction. For example, dose
mimicking models can incorporate parameters that reﬂect the uncertainties in a predicted dose distribution
(Zhang et al 2021). Similarly, inverse planning weight estimation models can incorporate an ensemble of dose
predictions to leverage the combined wisdom of multiple predictions (Babier et al 2021a). Note that these
optimziation models make dose predictions an intermediate step in a KBP pipeline.
Most KBP pipelines are developed as fully-automated pipelines that can replace human treatment planners
in the planning process (McIntosh et al 2017, Fan et al 2019, Bai et al 2020, Wortel et al 2021). These approaches
have demonstrated promising results in prospective research studies where a sizeable portion of KBP-generated
plans were considered inferior to human-generated plans, which suggests that there is an opportunity for
improvement (Cornell et al 2020, McIntosh et al 2021). In those cases, making manual adjustments to the KBPgenerated plan is non-trivial because they are generated by fully-automated pipelines that rely on the quality of
the data. In contrast to fully automated pipelines, semi-automated pipelines rely on both the quality of data and
human expertise, which puts less reliance on the data. For example, a semi-automated KBP pipeline could
enable human planners to improve upon a KBP-generated plan via an intuitive process (e.g. inverse planning)
and thereby provide a pipeline that leverages both data and human expertise.. In the KBP literature, however,
there are relatively few papers that describe tools that humans can intuitively interact with in semi-automated
KBP pipeline (Babier et al 2018, Bohara et al 2020, Kaderka et al 2021, Zhang et al 2022).
In this paper, we extend the results from the OpenKBP Grand Challenge with an international validation of
76 KBP pipelines. We made this extension, which we call OpenKBP-Opt, open to provide a benchmark for
future KBP optimization research and to lower the barriers for contributing to this research area. We also
demonstrate how KBP plan optimization models can be used to initialize a conventional inverse planning
process with good patient-speciﬁc parameters (i.e. objective weights). This relationship provides a mechanism
for transforming some existing KBP optimization models, which are fully-automated pipelines that impede
manual intervention, into semi-automated pipelines that promote human planners to improve upon a KBPgenerated plan via inverse planning (i.e. a familiar and intuitive process). The data and code to reproduce this
paper is publicly available at https://github.com/ababier/open-kbp-opt.

2. Materials and methods
Figure 2 separates our methods into ﬁve components. The ﬁrst three components (processing patient data,
developing dose prediction models, and generating KBP dose predictions) are based on the results from the
OpenKBP Grand Challenge. The ﬁnal two components (developing plan optimization models and generating
KBP treatment plans) are an extension of the OpenKBP Grand Challenge and the focus of this paper. Below, we
describe all ﬁve components and our analysis.
3
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2.1. Processing patient data
We obtained data for 340 patients (n = 340) with head-and-neck cancer from the OpenKBP Grand Challenge.
The data consisted of a training set (n = 200), a validation set (n = 40), and a testing set (n = 100). The plans
were delivered via 6 MV step-and-shoot IMRT from nine equidistant coplanar beams at angles 0◦, 40◦, K, 320◦.
Those beams were divided into a set of beamlets  , which make up a ﬂuence map. The relationship between the
intensity wb of beamlet b and dose dv deposited to voxel v was determined using the inﬂuence matrix Dv,b
generated by the IMRTP library from the Computational Environment for Radiotherapy Research (Deasy et al
2003) using MATLAB, and it is given by d v = åb Î  Dv, bwb.
2.2. Developing dose prediction models
All dose prediction models used in this paper were developed in the OpenKBP Grand Challenge (Babier et al
2021b). During the challenge, teams developed dose prediction models using identical training and validation
datasets with access only to ground truth data (i.e. reference dose) for the training set. Every dose prediction
model used a neural network architecture that was based on either a U-Net (Ronneberger et al 2015), V-Net
(Milletari et al 2016), or Pix2Pix (Isola et al 2017) architecture. Many of the best performing models also used
other generalizable techniques like ensembles (Nguyen et al 2021), one-cycle learning (Zimmermann et al 2021),
radiotherapy-speciﬁc loss functions (Gronberg et al 2021), and deep supervision (Liu et al 2021).
All teams competed to develop models that minimize one of two pre-deﬁned error metrics that quantiﬁed
the difference between the reference dose and a KBP-generated dose (i.e. their KBP dose predictions). The
metrics were: (1) dose error, which was the mean absolute voxel-by-voxel difference between two dose
distributions, and (2) dose-volume histogram (DVH) error, which was the absolute difference between a DVH
point from two dose distributions. The DVH error was evaluated on two and three DVH points for each organat-risk (OAR) and target, respectively. The OAR DVH points were the Dmean and D0.1cc, which was the mean
dose delivered to the OAR and the maximum dose delivered to 0.1 cc of the OAR, respectively. The target DVH
points were the D1, D95, and D99, which was the dose delivered to 1% (99th percentile), 95% (5th percentile), and
99% (1st percentile) of voxels in the target, respectively. The models were ranked according to: (1) dose score,
which was the average dose error of a model, and (2) DVH score, which was the average DVH error of a model.
2.3. Generating KBP dose predictions
In this paper, the OpenKBP organizers collaborated with teams that competed in the OpenKBP Grand
Challenge. The 28 teams that completed the ﬁnal phase of the OpenKBP Grand Challenge were invited to
participate in the OpenKBP-Opt project, and 21 of those teams agreed to participate. We obtained dose
predictions from the participating teams for each patient in the test set to create a dataset with 2100 dose
predictions (21 different predictions for each of the 100 patients). We observed that two models had dose scores
that were over two standard deviations (6.3 Gy) above the mean (4.0 Gy), whereas the rest were within half a
standard deviation (1.6 Gy) of the mean. Thus, we omitted those two outlier models and proceeded with only 19
KBP models (n = 1900 dose predictions).
2.4. Developing plan optimization models
Next, we formulated four dose mimicking models, which are a type of KBP optimization model. Each model
used the same set of structures and objective functions that are described in sections 2.4.1 and 2.4.2, respectively.
However, they differ in how they mimic (i.e. penalize differences) a speciﬁc dose distribution. In particular, they
each have a different cost function, outlined in section 2.4.3. Note that in this paper the terms objective function
and cost function refer to distinct concepts, and the cost functions in this paper are functions of objective
functions.
2.4.1. Structures
All of our optimization models used the same set of regions-of-interest (ROIs)  p for each patient p Î  in our
test set. The set  p contained OARs, targets, and optimization structures. The OARs were the brainstem, spinal
cord, right parotid, left parotid, larynx, esophagus, and mandible. Each target t was a planning target volume
(PTV) with a dose level θt, and those targets were the PTV56, PTV63, and PTV70. The optimization structures
were the limPostNeck, which was used to limit dose to the posterior neck, and six PTV ring structures (a 3 mm
ring and a 6 mm ring for each target). These were the same structures used to generate the plans in the original
OpenKBP dataset (Babier et al 2021b). Every ROI r Î  p was also divided into a set of voxels r .
2.4.2. Objective functions
Our models used the objective functions in table 1. Each objective function quantiﬁed a different measure of the
dose delivered to a single ROI r Î  p in a patient p Î  , which we call an objective value. Speciﬁcally, the
average and maximum dose objective function quantiﬁed the average dose and maximum dose delivered to an
4
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Table 1. The formulations for our objective functions.
Objective function
Average dose

mean (d v )

Maximum dose

max (d v )

Average dose over threshold

mean (d v - f )+

Average dose under threshold

mean ( f - d v )+

v Î r

v Î r

v Î r

v Î r

Table 2. The cost functions for each dose mimicking model that
minimize mean absolute (MeanAbs), max absolute (MaxAbs),
mean relative (MeanRel), and max relative (MaxRel) differences
between all pairs of the optimized and predicted objective
values (gm (w), gˆm ).
Dose mimicking model cost function
MeanAbs

mean (gm (w) - ^
gm )+ +  mean (gm (w) - ^
gm )-

MaxAbs

max (gm (w) - gˆm )

MeanRel
MaxRel

m Î p

m Î p

m Î p

gm (w) - gˆm +

(
max (

mean
m Î p
m Î p

gˆm
gm (w) - gˆm
gˆm

)
)

+  mean
m Î p

(

gm (w) - gˆm gˆm

)

ROI r, respectively. The average dose over and under threshold objective functions quantiﬁed the average dose
delivered to an ROI r that was over and under a dose threshold f, respectively. Our average dose over and under
threshold objective functions are similar to tail mean dose (Romeijn et al 2006) and conditional value-at-risk
(Rockafellar and Uryasev 2000), which are both deﬁned on the percentiles of a distribution.
In total, we considered 107 objectives functions: seven per OAR, three per target, and seven per optimization
structure. The objective functions for each OAR were the mean dose; maximum dose; and average dose over
thresholds of f equal to 0.25, 0.50, 0.75, 0.90, and 0.975 of the maximum predicted dose to that structure. The
objective functions for each target were the maximum dose, the average dose under a threshold f equal to the
dose level of the target (i.e. f = θt), and the average dose over a threshold f equal to ﬁve percent more than the
dose level of the target (i.e. f = 1.05θt). The objective functions for each optimization structure were the same as
the OAR objective functions. Not all patients had all ROIs, so the models associated with those patients had
fewer than 107 objective functions.
2.4.3. Model formulations
Our KBP optimization models performed dose mimicking to generate plans with optimized objective values
that closely matched the input objective values from a dose prediction. To streamline our model formulation, let
each m Î p index one of the 107 objective functions (as outlined in section 2.4.2), and let the elements in the
vector w represent beamlet intensities wb, " b Î  . Let gm(w) and ĝm be objective values of their corresponding
objective functions evaluated over the optimized plan and predicted dose, respectively. In all models, the cost
functions were formulated such that lower values of gm(w) were favored over higher values. Table 2 presents the
cost functions of our dose mimicking models. Each model minimized either the mean or max difference
between all corresponding pairs (gm (w), gˆm) of the objective values, which were quantiﬁed via an absolute
(gm (w) - gˆm ) or relative ((gm (w) - gˆm) gˆm) difference measure, resulting in four dose mimicking models. In
the mean difference models, we chose to prioritize the positive differences (i.e. where the optimized plan
objective value was higher than the predicted dose objective value) more than the negative differences, which we
assigned a small positive weight ò (ò = 0.0001 in our experiments). This was done to incentivize the model to do
at least as well as the dose prediction before striving to outperform the dose prediction on other objective
functions. In contrast, the max difference models used only a single term because the max difference naturally
incentivizes the model to outperform the prediction only once the plan outperforms the prediction across all
objective values (i.e. when gm (w)  gˆm, " m Î p ).
The main constraint in all four models was a constraint to limit plan complexity. In particular, the sum-ofpositive gradients (SPG) (Craft et al 2007) of all plans generated by the models was constrained to be less than or
equal to 65, which was a constraint in the reference plans (Babier et al 2021b). The remaining constraints were
simply auxiliary constraints (including auxiliary variables) used to linearize both the objective and cost functions
5
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Figure 3. An overview of our process. First, dose prediction models were developed with training and validation data. Second, those
models predicted dose for testing data that was used by the dose mimicking models to generate KBP plans.

(i.e. the formulations in table 1 and table 2). The optimization models were all formulated in Python 3.7 using
OR-Tools 9.1 and solved using Gurobi 9.1 on a single computer with an Intel i7-8700K (6-Core 3.7 GHz) CPU
and 16 GB of random access memory. Default parameters were used with the Gurobi solver except for Crossover
set to 0, Method set to 2, and BarConvTol set to 0.0001, which were selected based on past experience to improve
solve time without compromising solution quality.
2.5. Generating KBP treatment plans
Next, we assembled 76 KBP pipelines by combining the 19 dose prediction models with each of the four dose
mimicking models. Each pipeline was applied to the 100 patients in the testing set, resulting in 7600 KBP plans
(see ﬁgure 3). We used these plans in our analysis to measure the quality of the respective KBP models. We refer
to the plans generated by each dose mimicking model as MeanAbs, MaxAbs, MeanRel, and MaxRel plans.
Altogether, after completing the process in ﬁgure 3, we had dose distributions for a set of reference plans
(n = 100), predictions (n = 1900), and KBP plans generated by four dose mimicking models (n = 4 × 1900).
The reference plans are the plans that were released as part of the OpenKBP Grand Challenge, and the
predictions are dose distributions that were submitted by 19 teams in the ﬁnal testing phase of the challenge. In
general, there will be differences between the reference plan, prediction, and KBP plan dose distributions.
Differences between a dose prediction and its corresponding KBP plan are due to multiple factors including
noisy and undeliverable predictions. Differences between a KBP plan and its corresponding reference plan
reﬂect different trade-offs in the cost function used to generate these plans.
2.6. Analysis
We conducted three analyses to measure model performance in terms of dose error, DVH point differences, and
clinical criteria satisfaction. We also investigated the theoretical connection between our dose mimicking
models and inverse planning. Finally, we summarized empirical optimization metadata.
2.6.1. Dose score and error
We evaluated the KBP models using the dose score and dose error as deﬁned in section 2.2. We calculated the
Spearman rank order correlation of the dose score rank between the prediction models and corresponding KBP
pipelines. The distribution of dose error was also visualized using a box plot. A one-sided Wilcoxon signed-rank
test was used to evaluate whether the dose error of the optimization models was the same (null hypothesis) or
lower (alternative hypothesis) than the dose prediction models. For all hypothesis tests in this paper, P < 0.05
was considered signiﬁcant.
2.6.2. DVH point differences
To measure the relative quality of dose distributions from a clinical perspective, we examined the distribution of
DVH point differences between the reference and KBP-generated dose. The differences were evaluated over the
DVH points listed in section 2.2 and visualized using boxplots. We used the one-sided Wilcoxon signed-rank
test to evaluate whether the dose generated by all optimization models performed the same (null hypothesis) or
better (alternative hypothesis) than the dose predictions. This test was chosen to evaluate the aggregate
performance of all optimization models relative to the predictions. Lower values were better for Dmean, D0.1cc,
and D1; higher values were better for D95 and D99.
2.6.3. Expected clinical criteria satisfaction
As another measure of plan quality, we examined the proportion of clinical criteria that were satisﬁed by the
reference plans and KBP-generated dose. One criterion was evaluated for each ROI (see table 3). The target
6
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Table 3. The clinical criteria that we used to
evaluate dose distributions.
Structures
OARs
Brainstem
Spinal cord
Right parotid
Left parotid
Esophagus
Larynx
Mandible
Targets
PTV56
PTV63
PTV70

Clinical criteria

D0.1cc  50.0 Gy
D0.1cc  45.0 Gy
Dmean  26.0 Gy
Dmean  26.0 Gy
Dmean  45.0 Gy
Dmean  45.0 Gy
D0.1cc  73.5 Gy
D99
D99
D99

53.2 Gy
59.9 Gy
66.5 Gy

criteria were evaluated after overlap between targets, which was removed when processing patient data for the
OpenKBP dataset, was reinstated. We tabulated the proportion of clinical criteria that were satisﬁed by the
reference plans, dose predictions, MeanAbs plans, MaxAbs plans, MeanRel plans, MaxRel plans, and the plans
from the KBP pipeline that satisﬁed the most clinical criteria overall. We also plotted the proportion of OAR,
target, and all ROI clinical criteria that each of the 76 KBP pipelines achieved.
2.6.4. Theoretical analysis of dose mimicking models
To justify our choice of dose mimicking models, we conducted a theoretical analysis into their structure using
linear programming duality theory (Bertsimas and Tsitsiklis 1997, Chapter 4). This analysis was based on
previous literature that showed a connection between Bensonʼs method (Benson 1978), which identiﬁes
efﬁcient solutions to multi-objective optimization models, and estimating the weights for inverse planning
(Chan et al 2014). We were motivated to conduct a similar analysis as in Chan et al (2014) because our dose
mimicking models are similar to the formulations in Benson (1978). In particular, we linearized the dose
mimicking models, took their duals, and related the dual variables to objective weights aˆ m in a conventional
multi-objective inverse planning problem depicted in model (1):
minimize
w

å

m Î p

^ m gm ( w ) ,
a

subject to SPG  65,
Auxiliary constraints to linearize functions in Table 1 and 2.

(1)

2.6.5. Optimization metadata
Lastly, we summarized the metadata that each optimization model generated. In particular, we evaluated the
average proportion of objective weight that each model assigned to OAR, target, and optimization structure
objective functions. We also recorded the average, ﬁrst quartile, and third quartile solve times.

3. Results
In this section, we summarize the performance of the 19 dose predictions models, four dose mimicking models,
and 76 KBP pipelines. We also complete our theoretical analysis of dose mimicking models and summarize the
metadata generated by our experiments.
3.1. Dose score and error
Table 4 summarizes the rank order correlation between the dose prediction models and their corresponding
KBP pipelines. We found that the rank of a prediction model was positively correlated with its corresponding
KBP pipeline rank. However, there was a wide range in correlation from 0.50 to 0.62. This demonstrates that
high quality predictions are correlated with high quality plans, but this result also indicates that a dose prediction
model that outperforms a competitor will not always generate better plans when it is used as input to a dose
mimicking model. Additionally, the KBP plans generated by an optimization model that evaluated relative
differences (i.e. MeanRel and MaxRel) achieved higher rank order correlations than their counterparts that
evaluated absolute differences (i.e. MeanAbs and MaxAbs).
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Figure 4. The distribution of dose error over all KBP-generated dose (n = 1900 points in each box). Boxes indicate median and
interquartile range (IQR). Whiskers extend to the minimum of 1.5 times the IQR and the most extreme outlier.

Table 4. Each dose mimicking model is compared to the predictions in terms
of Spearman rank order correlation.

Rank order correlation
Rank order P-value

MeanAbs

MaxAbs

MeanRel

MaxRel

0.53
0.019

0.50
0.030

0.62
0.005

0.59
0.008

The dose errors of predictions and KBP plans are shown in ﬁgure 4. Two of the four sets of KBP plans (those
generated by MaxAbs and MaxRel) had a median dose error that was lower than the median dose error of the
predictions (2.79 Gy), implying that it is possible for optimization models to generate dose distributions that
more closely resemble the reference plan dose, compared to dose predictions. These two models also achieved a
signiﬁcantly lower error (P < 0.001) than predictions. The MaxAbs model achieved the lowest median dose
error (2.34 Gy).
3.2. DVH point differences
Figure 5 shows the DVH point differences between the reference dose and KBP-generated dose. In general, dose
mimicking tends to produce a plan dose that is signiﬁcantly better than the dose it received as input from a dose
prediction model. In particular, the KBP plan dose is signiﬁcantly better on 18 of the 23 DVH points than the
predicted dose (all OAR points and four target points). The ﬁve DVH points where the plans were not
signiﬁcantly better are the three D95 points and two D99 points.
3.3. Expected clinical criteria satisfaction
In table 5, we compare the percentage of criteria that were satisﬁed by the reference plans (n = 100), predictions
(n = 1900), plans generated by each of the four dose mimicking models (n = 4 × 1900), and plans generated by
the top performing KBP pipeline (n = 100). We use the term baselines to refer to the reference dose and dose
predictions collectively. The top performing KBP pipeline (denoted ‘Best’ in table 5) was deﬁned as the single
pipeline (i.e. the combination of one dose prediction model and one dose mimicking model) whose plans
satisﬁed the most clinical criteria. Of all dose mimicking models, the MaxRel and MeanAbs models generated
plans that satisﬁed the fewest (69.8%) and most (72.9%) ROI clinical criteria, respectively. For comparison,
predictions only satisﬁed 66.2% of all clinical criteria, which was 3.5 percentage points lower than the reference
plans (69.7%). The best KBP pipeline, which used the MeanAbs model and one of the 19 prediction models
(discussed later), satisﬁed 77.0% of all ROI clinical criteria.
In general, clinical criteria satisfaction varied across each ROI criterion. The brainstem, spinal cord,
esophagus, and mandible criteria were each satisﬁed more than 85% of the time across all the baselines and our
dose mimicking models in table 5. The right parotid, left parotid, and larynx were satisﬁed less than 40% of the
time by the the two baselines. In contrast, each of our four dose mimicking models generated a higher average
criteria satisfaction for these ROIs compared to the baselines. In fact, some were substantially higher. For
example, the average criteria satisfaction of the MeanAbs model on the larynx was 71.5%, compared to an
average of 36.2% for the baselines. In aggregate over all 19 prediction models, the performance of the four dose
mimicking model was comparable or slightly worse than the reference dose in terms of criteria satisfaction in the
targets. However, the best KBP pipeline outperformed the baselines on all criteria.
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Figure 5. The distribution of DVH point differences between the reference dose and each set of KBP-generated dose. Negative
differences indicate cases where the KBP-generated dose had a lower DVH point than the reference dose, and arrows indicate the
direction where KBP-generated dose is considered better than reference dose for each DVH point. Boxes indicate median and IQR.
Whiskers extend to the minimum of 1.5 times the IQR and the most extreme outlier.

Table 5. The percentage of clinical criteria satisﬁed in each set of KBP-generated dose. Note that ‘Best’ is deﬁned as the
top performing KBP pipeline that generated plans that satisﬁed the most ROI clinical criteria. The highest percentage of
satisﬁed criteria is bolded in each row.
Baselines

OARs
Brainstem
Spinal cord
Right parotid
Left parotid
Esophagus
Larynx
Mandible
Targets
PTV56
PTV63
PTV70
All
OARs
Targets
ROIs

Dose mimicking models

Reference

Prediction

MeanAbs

MaxAbs

MeanRel

MaxRel

Best

96.6
95.5
32.3
30.6
93.0
37.7
87.5

97.3
92.7
32.7
30.1
92.7
34.7
89.4

100.0
99.7
46.1
43.7
100.0
71.5
99.6

99.5
97.3
38.9
35.0
95.2
44.9
98.7

100.0
100.0
45.0
41.9
100.0
58.8
99.2

98.5
95.6
38.0
35.0
97.3
44.6
99.0

100.0
100.0
41.4
40.8
100.0
67.9
93.1

91.2
90.5
64.0

85.8
86.2
45.7

83.3
82.2
37.2

91.8
89.6
51.6

84.1
84.8
40.1

84.6
84.8
47.7

96.7
92.9
66.0

65.5
79.4
69.7

65.1
68.7
66.2

77.1
63.3
72.9

70.6
74.2
71.7

75.3
65.3
72.3

70.2
68.8
69.8

74.5
82.8
77.0
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Figure 6 summarizes the clinical criteria that were satisﬁed by each of the 76 KBP pipelines that we evaluated.
The spread in OAR criteria satisfaction across all 19 models (55.4%–82.1%) was lower than that of target criteria
satisfaction (24.5%–89.7%), see ﬁgures 6(a) and (b), respectively. Overall, the MeanAbs model generated plans
that satisﬁed more criteria than the other three dose mimicking models for 16 of the 19 dose prediction models
(see ﬁgure 6(c)). Additionally, the pipelines that used better prediction models (i.e. lower dose score ranks)
generally produced plans with higher criteria satisfaction. Interestingly, however, the best performing KBP
pipeline (from the last column of table 5) used the dose prediction model that ranked 16th in terms of dose score.
Note that the poor performing KBP pipelines used the 12th, 13th, 17th, 18th, and 19th ranked dose prediction
models. Since the dose mimicking columns in table 5 included all KBP pipelines, these poor performing models
contributed to low performance that was most pronounced on the target criteria. In contrast, many of the KBP
pipelines that used the top ranked models prediction models clearly performed much better on target criteria.
3.4. Theoretical analysis of dose mimicking models
We use theoretical results from Chan et al (2014) to demonstrate the connection between our dose mimicking
formulations and inverse planning. The inverse planning problem presented previously as model (1), is
presented again in vector and matrix notation to follow Chan et al (2014). The objective functions are
represented as the rows of the matrix C and the objective weights are represented by the vector â . The decision
variables, which include the ﬂuence variables (wb, " b Î  ) and auxiliary variables, are represented by vector x.
The SPG and auxiliary constraints are encoded in the matrix A and vector b. With this vector and matrix
notation, we can write the inverse planning problem as model (2):
^ ¢Cx ,
minimize a
x

subject to Ax = b ,
x  0.

(2)

Table 6 presents the formulations of the four dose mimicking models and their respective dual models in
vector and matrix notation. The positive and negative differences between optimized objective values Cx and
predicted objective values Cxˆ are represented by vectors σ and δ, respectively. The max difference between the
optimized and predicted objective values is expressed as a scalar ζ. The dual variables of the dose mimicking
models are denoted by α and p. The vectors of all 0 and 1 are denoted by 0 and e, respectively. The symbol e
denotes element-wise multiplication of two vectors and prime denotes the transpose operator.
Next, we complete our theoretical analysis. We ﬁrst observe that the weight estimation technique developed
in Chan et al (2014) is identical to our dual formulations (see table 6) except for the constraints related to the
objective weights α, which prevent trivial solutions to the weight estimation technique. In the context of our
models, proposition 5 from Chan et al (2014) establishes that an optimal decision vector x* from each dose
mimicking model is also optimal for the inverse planning model with objective weights equal to the optimal dual
vector α*, which is a byproduct of solving the corresponding dose mimicking model. This result means that the
solution to each dose mimicking model is also optimal to an inverse planning model with a particular set of
ˆ = a*). Additionally, by complementary
objective weights (i.e. x* is an optimal solution for model (2) when a
slackness, a plan generated by the MeanAbs or MeanRel model will achieve the same objective values (i.e. Cx*) as
a plan that is optimal for its corresponding inverse planning model. These theoretical results were validated
computationally but omitted for brevity.
3.5. Optimization metadata
In table 7, we present metadata that was generated by each optimization model, which assigned a different
proportion of weight to the objectives for each group of ROIs. The models that evaluate relative differences (i.e.
MeanRel and MaxRel) spread the proportion of weight relatively evenly between the OAR and target objectives,
but the other two models assigned the majority of the weight to target objectives with no more than 0.018 weight
to OARs. Additionally, the optimization structures generally received the smallest proportion of weight with the
exception of the MaxAbs model, which assigned more weight to optimization structure objectives (0.170) than
OAR objectives (0.011). There was also a wide range in average solve time between the models (222–393 s). On
average, the MaxAbs model was the fastest.

4. Discussion
KBP research is ﬂourishing. However, optimization models for KBP (e.g. dose mimicking) have received much
less attention in the literature than dose prediction models. In this paper, we developed four dose mimicking
models and evaluated their performance with 19 different dose prediction models, which were inputs to the
10
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Figure 6. The percentage of all (a) OAR, (b) target, and (c) ROI clinical criteria that were satisﬁed by each KBP pipeline, which are
labeled by their prediction dose score rank. The points indicate the percentage of satisﬁed criteria for n = 100 patients. A dashed line
indicates the percentage of criteria satisﬁed by reference plans.
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Table 6. The dose mimicking models presented in vector and matrix notation with their dual
models. Terms that follow colons indicate the dual variables for that constraint.

MeanAbs

MaxAbs

MeanRel

MaxRel

Dose mimicking model

Dual model

minimize e ¢s +  e ¢d

¢
^ - bp
minimize a ¢Cx

^+s+d :a
subject to Cx = Cx
Ax = b
:p
x0
s0
d0

¢
subject to C ¢a  Ap
:x
ae
:s
a  e
:d

minimize z

¢
^ - bp
minimize a ¢Cx

^ + ze : a
subject to Cx  Cx
Ax = b
:p
x0

¢
subject to C ¢a  Ap
:x

minimize e ¢s +  e ¢d

¢
^ - bp
minimize a ¢Cx

^  (e + s + d) : a
subject to Cx = Cx
Ax = b
:p
x0
s0
d0

¢
subject to C ¢a  Ap
:x
^e :s
a  Cx
^  e : d
a  Cx

minimize z

¢
^ - bp
minimize a ¢Cx

^  (e + z e) : a
subject to Cx  Cx
Ax = b
:p
x0

¢
subject to C ¢a  Ap
:x
¢
^
a Cx = 1 : z
a0

a, p

x, s, d

x, z

a, p

a ¢e = 1
a0

x, s, d

:z

a, p

x, z

a, p

Table 7. A summary of the average proportion of objective weight that was
assigned to each group of ROI objectives and the solve time statistics of each
dose mimicking model (n = 1900 plans in each column).

Objective weight
OARs
Targets
Optimization structures
Solve time (s)
Average
First quartile
Third quartile

MeanAbs

MaxAbs

MeanRel

MaxRel

0.018
0.976
0.006

0.011
0.819
0.170

0.554
0.418
0.028

0.417
0.569
0.014

389
192
502

222
107
261

367
183
481

393
188
507

optimization models. We showed that both the dose prediction model and optimization model contributed to
considerable variation in the quality of plans generated by the corresponding KBP pipeline. Additionally, we
conducted a theoretical analysis to show that our KBP optimization models generate plans that are optimal for a
multi-objective inverse planning model with particular weights.
Our data and code is published at https://github.com/ababier/open-kbp-opt to enable others to reproduce
our results, which meets the gold standard in reproducibility (Heil et al 2021). Our data includes the ﬁrst open
dataset with reference plans and predictions. We hope that this effort produces a common resource and lowers
the barriers for future KBP optimization research, given that researchers must currently acquire their own
private datasets and develop in-house prediction models before they can start testing new KBP optimization
models.
Our open dataset contains the data for 100 patients who were treated with IMRT and a sample of high quality
dose predictions for those same patients. The dataset was curated for the purpose of developing new ﬂuencebased KBP optimization models that use ROI masks, dose inﬂuence matrices, and dose predictions. The dose
predictions were generated by 21 dose prediction models that were developed by an international group of
researchers, which provided a diverse sample of realistic inputs for a KBP optimization model. Two of those
prediction models (the 20th and 21st ranked models) were removed from our analysis because their dose scores
12

Phys. Med. Biol. 67 (2022) 185012

A Babier et al

were poor, which we elaborated on in section 2.3. For completeness, however, those 200 predictions are also
available as part of our dataset.
We also performed a theoretical analysis to justify our dose mimicking models. Our key theoretical ﬁnding
was that dose mimicking and conventional inverse planning are equivalent under certain speciﬁcations of the
objective weights. This allows us to interpret previous weight estimation techniques (Chan et al 2014) through
the more intuitive lens of dose mimicking models. Finally, by connecting dose mimicking to inverse planning,
there is the potential to convert fully-automated KBP pipelines into semi-automated pipelines. Speciﬁcally, we
use dose mimicking to generate a high-quality plan with its corresponding objective weights, which reﬂect the
priorities of the input dose prediction, and those objective weights can be used in an inverse planning model (i.e.
model (3)). This is advantageous because it enables human planners to improve the quality of plans generated by
KBP via a conventional inverse planning process. By enabling this intuitive human interaction, we can create a
semi-automated KBP pipeline that is aligned with a common belief that AI will augment, rather than replace, the
duties of healthcare practitioners (Ahuja 2019).
Evaluating the performance of optimization models using many different dose predictions helps to identify
interaction effects between these two stages of a KBP pipeline (Babier et al 2020). For example, the 16th ranked
dose prediction model generated lower quality predictions (in terms of dose error) than most of its competitors.
However, when used in a KBP pipeline with the right optimization model, in this case the MeanAbs model, it
generated high quality plans that achieved more clinical criteria than any other KBP pipeline. In other words, the
errors made by the 16th ranked model that contribute to its low prediction quality were corrected by the KBP
optimization model. Note that the 16th ranked prediction model achieved the fewest OAR criteria (55.4%) and
the third highest target criteria (81.5%), which suggests that the MeanAbs model was adept at correcting
prediction errors related to under and over predicting OAR and target criteria satisfaction, respectively. Since
these interaction effects contribute to considerable variation in quality, it is important to evaluate KBP
optimization models across a diverse set of dose prediction models. Additionally, if we can understand what
types of prediction error are most highly correlated with KBP plan quality we could propose better evaluation
metrics to drive KBP prediction research towards making predictions that consistently translate into higher
quality plans.
As in the original OpenKBP Grand Challenge, a limitation of this work is that we use synthetic dose
distributions (i.e. the reference dose) as a substitute for real clinical dose. Although these dose distributions were
subject to less quality assurance than clinical plans, they were previously shown to be of similar quality (Babier
et al 2021b). A second limitation of this work is that the dose prediction models were developed with the goal of
optimizing the dose and DVH scores. There may be other scoring metrics that are better suited for developing a
dose prediction model that excels in a KBP pipeline. This is a possible direction for future research. Lastly, this
work only covers a single site and treatment modality. There is no guarantee that KBP optimization models that
are developed with this dataset can generalize to other sites or treatment modalities.

5. Conclusion
In this paper, we combined the dose predictions contributed by a large international team with several KBP
optimization models, resulting in 76 KBP pipelines. This was the largest international effort to date on KBP
pipeline evaluation. We found that the best performing pipeline signiﬁcantly outperformed the baselines. In the
interest of reproducibility, our data and code is freely available.
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